Rapid resolution of quadriplegic CIDP by combined plasmapheresis and IVIg

Neurology

Volumn 62, Issue 1, 2004, Pages 155-156

  Walk, David ^a   Li, Laura Y J ^a   Parry, Gareth J ^a   Day, John W ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CHILD; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DEMYELINATION; DIPLOPIA; DYSPNEA; FACIAL NERVE PARALYSIS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; QUADRIPLEGIA; REMYELINIZATION;

EID: 0347092031     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.62.1.155     Document Type: Article

References (7)

1. Haupt WF, Birkmann C, van der Ven C, Pawlik G. Apheresis and selective adsorption plus immunoglobulin treatment in Guillain-Barre syndrome. Ther Apher 2000;4:198-200.
2. Berger AR, Herskovitz S, Scelsa S. The restoration of IVIg efficacy by plasma exchange in CIDP. Neurology 1995;45:1628-1629.
3. Latov N. Diagnosis of CIDP. Neurology 2002;59(suppl 6):S2-6.
4. Nydegger UE, Rieben R, Jungi TW. Synergy between plasma exchange and intravenous immunoglobulin. Curr Stud Hematol Blood Transfus 1990;57:31-50.
5. Dalakas MC. Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies. Neurology 2002;59(suppl 6):S13-21.
6. Yu Z, Lennon VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med 1999;340:227-228.
7. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of MG mediated through the inhibitory Fc receptor. Science 2001;291:484-486.